Company news
Scinopharm Taiwan, Ltd. (TWSE:1789) news
Scinopharm Taiwan, Ltd. news releases on 6ix. Latest, Jan 5, 2026: ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment…
Press releases & updates
ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis
January 5, 2026
ScinoPharm Taiwan : Board of Directors approved the company's consolidated financial report of Q2, 2022
August 5, 2022
ScinoPharm Taiwan : To Announce the ex-dividend record date and cash dividend distribution date approved by the Board of Directors
May 30, 2022
ScinoPharm Taiwan : Announce the Company's 2022 Shareholders' Meeting approved to release the Directors and their representatives from non-competition restrictions
May 30, 2022
Scinopharm Taiwan : President & CEO Dr. Jo Shen to Retire, Dr. Yung-Fa (Fred) Chen to Succeed
July 11, 2014